Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

This Government Contract opportunity from Department Of Defense was posted on April 6, 2023. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

MHS GENESIS Support

Closed
HT003823R0003Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

General Info

NAICS

541512 - Computer Systems Design Services

Place of Performance

VA, USA

Set-Aside

NONE

Documents

0

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PhaseClosed
Posted

special-notice

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → Defense Health Agency
Contacts1 person available
OfficeROSSLYN, VA, 22209, USA
Office AddressROSSLYN, VA, 22209, USA
Contacts
Jason Pickart Contracting and Agreements Officer

Full Description

Show more
REQUEST FOR INFORMATION The Department of Defense (DoD) Healthcare Management System Modernization (DMHSM) Program oversees the acquisition and deployment of the DoD's new Electronic Health Record (EHR), MHS GENESIS. MHS GENESIS is an automated medical information system that supports health care administration and delivery at Department of Defense (DOD) Military Treatment Facilities (MTFs) and Theater Medicine. These MTFs include hospitals, outlying medical clinics and outlying dental clinics. Theater Medicine includes (but is not limited to) ships, submarines, hospital ships, forward resuscitative sites, theater hospitals, aeromedical staging facilities, and aeromedical evacuation teams. It provides access to authoritative sources of data to enable improved population health, patient safety, and quality of care. It supports an enhanced patient care experience and serves as a tool to maximize medical readiness for our military. MHS GENESIS unifies and increases accessibility of integrated, evidenced-based healthcare delivery and decision-making.? For the purposes of this request for information (RFI), DHMSM is assessing best business practices for (1) system and software engineering; (2) system integration; (3) installation, testing, and deployment; (4) lifecycle logistics support to include user training; (5) software release management; (6) operations and maintenance (O&M) support; and (7) business intelligence and research. Visit the interactive Genesis of MHS GENESIS timeline?to learn more about the development of MHS GENESIS and its deployment across the MHS. The hyperlink is listed below. Questions for RFI Respondents The Government seeks responses to the following questions. What are commercial best practices for EHR end user optimization? ? In your experience, what level of integration work is required for sustaining and optimizing a COTS system in a large-scale DoD enterprise? ? What are commercial best practices for operating health related system of systems in a cloud-based environment?? What scale of integration efforts has your company supported for a Major Automated information System in the Defense Department?? What are commercial best practices/standard service level agreements?for an EHR such as MHS GENESIS?incidents? ? Tell us about your technical capability to perform within the construct of a multi-billion dollars requirements like MHS GENESIS, in whole or in part. At a minimum, demonstrate your management and technical capabilities for attracting, recruiting, and retaining top-quality employees with the technical skills, and expertise and experience needed to meet such effort. Please share your technical capability as well as the supporting material that demonstrates a full understanding of the methodology and approach.? Share your knowledge of contracting vehicles that may be aligned with the government's RFI and that may provide the best value for this requirement. List the contract vehicle(s) by name, Period of Performance, Agency, Ceiling, relevant North American Industry Classification System (NAICS), and if a Prime or Subcontractor.? List any successful strategies/methodologies used to manage interoperability of data across EHR systems.?? What are commercial best practices for training and adoption of new EHR capabilities for current users? ? What is an effective commercial approach to training capabilities that require an interface with the main EHR system? For example, capabilities that require new equipment (e.g. supply chain scan gun, EHR on a tablet, signature pads, etc.) or interfaces with 3rd party systems (e.g. DEERS, external billing systems, etc.)? In this environment, what types of profit incentives are effective relating to performance?? Instructions for Submission RFI respondents are encouraged to provide responses and comments to the questions above. Responses and comments may be utilized in the development of additions or modification to future DHMSM Draft RFPs. DHMSM requests that responses to the RFI be submitted to the POC identified below by 21 April 2023. Please keep responses for the above questions to no more than 15 pages. If you choose to provide a capability statement, ensure it is within 5-10 pages. For your questions, please continue a dialogue with the DHMSM PMO and other industry partners, by creating an account at https://connect.bidscale.com/hive-hub. ? No verbal responses will be accepted. Proprietary information may be submitted; however, RFI respondents are responsible for adequately marking proprietary, restricted or competition sensitive information contained in their response. All submissions will be protected from disclosure outside of the DHMSM Program Office. In addition, RFI respondents should be aware that the DHMSM Program Office may utilize contractor support personnel from the below listed companies (under existing contracts) to review responses and information submitted. These companies and individual employees are bound contractually by Organizational Conflict of Interest and disclosure clauses with respect to proprietary information, and they will take all reasonable action necessary to preclude unauthorized use or disclosure of an RFI respondent's proprietary data. RFI responses MUST clearly state whether permission is granted allowing the program office support contractors identified below access to any proprietary information. Boston Consulting Group ZYGOS Consulting Trex Solutions LLC This RFI is not a solicitation. This RFI is for planning purposes only. It does not constitute an RFP or a promise to issue an RFP in the future. This RFI does not commit the Government to contract for any supply or service whatsoever. Further, DHMSM is not seeking proposals at this time, and will not accept unsolicited proposals. Respondents are advised that the Government will not pay for any information or administrative costs incurred in response to this RFI. All costs associated with responding to this RFI will be solely at the responding party's expense. Participation is not mandatory or required; participation or response to this RFI is not a prerequisite for any future procurement activities.

More opportunities from Department Of Defense → Defense Health Agency

Same awarding agency

NAICS: 811210
New
Federal
Zeiss Meditec Ophthalmology Equipment Maintenance
Solicitation # HT940627QE003
Solicitation HT940627QE003 is a Request for Quote issued by the Defense Health Agency, Healthcare Contracting Division-Southeast, for a firm-fixed-price contract to provide full-service maintenance for Zeiss MediTec ophthalmology equipment at the Naval Medical Center Camp Lejeune in North Carolina. The scope of work includes regularly scheduled preventative maintenance, timely onsite repairs, and software updates for specific devices, including the CIRRUS 5000, IOLMASTER 700, HFA3 B60, and ATLAS 900. All services must be performed according to manufacturer recommendations and applicable FDA regulations. The contract consists of a base period from December 1, 2026, to November 30, 2027, with four subsequent option periods extending the potential performance through November 30, 2031. This procurement is a total small business set-aside under NAICS code 811210. Award will be made based on the Lowest Priced Technically Acceptable (LPTA) basis, where technical capability is evaluated independently of price. Offerors must submit two separate volumes: Volume I for technical capability, which must describe the functional approach and methodology without identifying company names or logos, and Volume II for comprehensive pricing. Quotes are due by 8:00 am Eastern Time on October 29, 2026. Payment and invoicing will be processed electronically through the Wide Area WorkFlow system.
Electronic and Precision Equipment Repair and Maintenance

POSTED

1 day ago

DEADLINE

in 9 days
View Details
NAICS: 541715
New
Federal
Prototype development for Battlefield Wound Infection Prevention and Treatment (BWI P&T) Barrier Combination
Solicitation # HT9427-26-R-E020
The Defense Health Agency Contracting Activity is seeking a single award for the development of a Battlefield Wound Infection Prevention and Treatment Barrier Combination prototype. This product must integrate a physical wound barrier with antimicrobial and antifungal properties to prevent the spread of organisms and systemic infections in combat scenarios. The project aims to advance technologies from a preferred Technology Readiness Level of 5 or higher to a final state of TRL 7 or 8, culminating in mandatory U.S. Food and Drug Administration approval or clearance. The scope of work includes preclinical testing, human clinical trials, and the submission of regulatory packages such as New Drug Applications or Premarket Approval Applications. This procurement is conducted under prototype Other Transaction Authority 10 U.S.C. 4022, meaning standard FAR and DFARS regulations do not apply unless expressly referenced. The estimated period of performance is 48 months, divided into three primary objectives: prototype demonstration, clinical studies and regulatory submissions, and final FDA clearance. Proposals are due by November 6, 2026, and must be submitted in three distinct volumes covering technical approach, management capability, and administrative cost and price. To be eligible, offerors must be registered in the System for Award Management and meet specific criteria, such as being a nontraditional defense contractor or a small business.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

1 day ago

DEADLINE

in 17 days
View Details

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS